BARCLAYS PLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AC4. A total of 10 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,709
-99.9%
2,345,000
-54.0%
0.00%
-83.3%
Q3 2022$5,335,0005,100,0000.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
READYSTATE ASSET MANAGEMENT LP 9,000,000$10,417,5002.55%
Opti Capital Management, LP 20,000,000$23,138,6002.00%
Boussard & Gavaudan Investment Management LLP 12,150$13,886,6021.54%
SSI INVESTMENT MANAGEMENT LLC 19,470,000$22,439,1801.42%
LINDEN ADVISORS LP 106,250,000$122,850,9721.29%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 36,000,000$41,5811.14%
Polar Asset Management Partners Inc. 80,000,000$92,493,8571.13%
WOLVERINE ASSET MANAGEMENT LLC 77,475,000$89,617,7930.93%
TENOR CAPITAL MANAGEMENT Co., L.P. 30,000,000$34,822,1640.83%
WHITEBOX ADVISORS LLC 14,870,000$17,137,6750.47%
View complete list of SAREPTA THERAPEUTICS INC shareholders